DCD肝移植术后并发症的变迁_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 叶啟发 ^1,2 , 曾宪鹏 ¹

1. ;
2. ;

Corresponding author：

叶啟发, Email: yqf_china@163.com

Keywords：

DOI：

10.7507/1007-9424.20150272

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 叶啟发, 曾宪鹏. DCD肝移植术后并发症的变迁. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2015, 22(9): 1032-1035. doi: 10.7507/1007-9424.20150272 Copy

1.	Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc, 1995, 27(5):2893-2894.
2.	Fondevila C, Hessheimer AJ, Flores E, et al. Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant, 2012, 12(1):162-170.
3.	Jiménez-Galanes S, Meneu-Diaz MJ, Elola-Olaso AM, et al. Liver transplantation using uncontrolled non-heart-beating donors under normothermic extracorporeal membrane oxygenation. Liver Transpl, 2009, 15(9):1110-1118.
4.	刘永锋. 中国心脏死亡器官捐献工作指南(第2版). 中华移植杂志:电子版, 2012, 32(3):221-224.
5.	D'Alessandro AM, Hoffmann RM, Knechtle SJ, et al. Liver trans-plantation from controlled non-heart-beating donors. Surgery, 2000, 128(4):579-588.
6.	Abt P, Crawford M, Desai N, et al. Liver transplantation from controlled non-heart-beating donors:an increased incidence of biliary complications. Transplantation, 2003, 75(10):1659-1663.
7.	Manzarbeitia CY, Ortiz JA, Jeon H, et al. Long-term outcome of controlled, non-heart-beating donor liver transplantation. Transplantation, 2004, 78(2):211-215.
8.	Abt PL, Desai NM, Crawford MD, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg, 2004, 239(1):87-92.
9.	Merion RM, Pelletier SJ, Goodrich N, et al. Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg, 2006, 244(4):555-562.
10.	Foley DP, Fernandez LA, Leverson G, et al. Donation after cardiac death:the University of Wisconsin experience with liver transplan-tation. Ann Surg, 2005, 242(5):724-731.
11.	Fujita S, Mizuno S, Fujikawa T, et al. Liver transplantation from donation after cardiac death:a single center experience. Transplan-tation, 2007, 84(1):46-49.
12.	Dubbeld J, van Hoek B, Ringers J, et al. Biliary complications after liver transplantation from donation after cardiac death donors:an analysis of risk factors and long-term outcome from a single center. Ann Surg, 2015, 261(3):e64.
13.	Yamamoto S, Wilczek HE, Duraj FF, et al. Liver transplantation with grafts from controlled donors after cardiac death:a 20-year follow-up at a single center. Am J Transplant, 2010, 10(3):602-611.
14.	Evans PC, Smith S, Hirschfield G, et al. Recipient HLA-DR3, tumour necrosis factor-alpha promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are interrelated risk factors for chronic rejection of liver grafts. J Hepatol, 2001, 34(5):711-715.
15.	Seehofer D, Eurich D, Veltzke-Schlieker W, et al. Biliary complica-tions after liver transplantation:old problems and new challenges. Am J Transplant, 2013, 13(2):253-265.
16.	Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation:a meta-analysis. Ann Surg, 2011, 253(2):259-264.
17.	D'Alessandro AM, Fernandez LA, Chin LT, et al. Donation after cardiac death:the University of Wisconsin experience. Ann Trans-plant, 2004. 9(1):68-71.
18.	Wigmore SJ. Current challenges in liver transplantation following donation after cardiac death. Transplantation, 2010, 90(10):1048-1049.
19.	Welling TH, Heidt DG, Englesbe MJ, et al. Biliary complications following liver transplantation in the model for end-stage liver disease era:effect of donor, recipient, and technical factors. Liver Transpl, 2008, 14(1):73-80.
20.	Leithead JA, Tariciotti L, Gunson B, et al. Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury. Am J Transplant, 2012, 12(4):965-975.
21.	Raia S, Nery JR, Mies S. Liver transplantation from live donors. Lancet, 1989, 2(8661):497.
22.	Gad EH, Alsebaey A, Lotfy M, et al. Complications and mortality after adult to adult living donor liver transplantation:a retrospective cohort study. Ann Med Surg (Lond), 2015, 4(2):162-171.
23.	Muiesan P, Vergani D, Mieli-Vergani G. Liver transplantation in children. J Hepatol, 2007, 46(2):340-348.
24.	Tessier ME, Harpavat S, Shepherd RW, et al. Beyond the pediatric end-stage liver disease system:solutions for infants with biliary atresia requiring liver transplant. World J Gastroenterol, 2014, 20(32):11062-11068.
25.	Kyoden Y, Tamura S, Sugawara Y, et al. Outcome of living donor liver transplantation for post-Kasai biliary atresia in adults. Liver Transpl, 2008, 14(2):186-192.
26.	Duffy JP, Hong JC, Farmer DG, et al. Vascular complications of orthotopic liver transplantation:experience in more than 4 200 patients. J Am Coll Surg, 2009, 208(5):896-905.
27.	张明满, 任志美, 康权, 等. 亲属活体及心脏死亡器官捐赠供肝儿童肝移植51例疗效分析. 中华器官移植杂志, 2013, 34(12):712-715.
28.	刘敏, 罗庆, 迭小红, 等. 儿童心脏死亡器官捐献供肝肝移植术后肝动脉并发症的诊治体会. 中华小儿外科杂志, 2015, 36(4):282-285.
29.	Reichman TW, Katchman H, Tanaka T, et al. Living donor versus deceased donor liver transplantation:a surgeon-matched comparison of recipient morbidity and outcomes. Transpl Int, 2013, 26(8):780-787.
30.	Fisher RA, Cotterell AH, Maluf DG, et al. Adult living donor versus deceased donor liver transplantation:a 10-year prospective single center experience. Ann Hepatol, 2009, 8(4):298-307.
31.	Wan P, Yu X, Xia Q. Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation:a systematic review and meta-analysis. Liver Transpl, 2014, 20(4):425-436.
32.	Gómez CM, Dumonceau JM, Marcolongo M, et al. Endoscopic management of biliary complications after adult living-donor versus deceased-donor liver transplantation. Transplantation, 2009, 88 (11):1280-1285.
33.	Li C, Mi K, Wen T, et al. Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation. PLoS One, 2011, 6(11):e27366.
34.	Kulik LM, Fisher RA, Rodrigo DR, et al. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma:results of the A2ALL cohort. Am J Transplant, 2012, 12(11):2997-3007.
35.	Vakili K, Pomposelli JJ, Cheah YL, et al. Living donor liver transp-lantation for hepatocellular carcinoma:increased recurrence but improved survival. Liver Transpl, 2009, 15(12):1861-1866.
36.	Lo CM, Fan ST, Liu CL, et al. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg, 2007, 94(1):78-86.
37.	Sandhu L, Sandroussi C, Guba M, et al. Living donor liver transp-lantation versus deceased donor liver transplantation for hepatoce-llular carcinoma:comparable survival and recurrence. Liver Transpl, 2012, 18(3):315-322.
38.	Bhangui P, Vibert E, Majno P, et al. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma:living versus deceased donor transplantation. Hepatology, 2011, 53(5):1570-1579.
39.	da Silva RF, Raphe R, Felício HC, et al. Prevalence, treatment, and outcomes of the hepatic artery stenosis after liver transplantation. Transplant Proc, 2008, 40(3):805-807.
40.	Starzl TE, Groth CG, Brettschneider L, et al. Orthotopic homotran-splantation of the human liver. Ann Surg, 1968, 168(3):392-415.
41.	Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg, 1989, 210(5):649-652.
42.	Belghiti J, Panis Y, Sauvanet A, et al. A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion. Surg Gynecol Obstet, 1992, 175(3):270-272.
43.	Mehrabi A, Mood ZA, Fonouni H, et al. A single-center experience of 500 liver transplants using the modified piggyback technique by Belghiti. Liver Transpl, 2009, 15(5):466-474.

1. Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc, 1995, 27(5):2893-2894.
2. Fondevila C, Hessheimer AJ, Flores E, et al. Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant, 2012, 12(1):162-170.
3. Jiménez-Galanes S, Meneu-Diaz MJ, Elola-Olaso AM, et al. Liver transplantation using uncontrolled non-heart-beating donors under normothermic extracorporeal membrane oxygenation. Liver Transpl, 2009, 15(9):1110-1118.
4. 刘永锋. 中国心脏死亡器官捐献工作指南(第2版). 中华移植杂志:电子版, 2012, 32(3):221-224.
5. D'Alessandro AM, Hoffmann RM, Knechtle SJ, et al. Liver trans-plantation from controlled non-heart-beating donors. Surgery, 2000, 128(4):579-588.
6. Abt P, Crawford M, Desai N, et al. Liver transplantation from controlled non-heart-beating donors:an increased incidence of biliary complications. Transplantation, 2003, 75(10):1659-1663.
7. Manzarbeitia CY, Ortiz JA, Jeon H, et al. Long-term outcome of controlled, non-heart-beating donor liver transplantation. Transplantation, 2004, 78(2):211-215.
8. Abt PL, Desai NM, Crawford MD, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg, 2004, 239(1):87-92.
9. Merion RM, Pelletier SJ, Goodrich N, et al. Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg, 2006, 244(4):555-562.
10. Foley DP, Fernandez LA, Leverson G, et al. Donation after cardiac death:the University of Wisconsin experience with liver transplan-tation. Ann Surg, 2005, 242(5):724-731.
11. Fujita S, Mizuno S, Fujikawa T, et al. Liver transplantation from donation after cardiac death:a single center experience. Transplan-tation, 2007, 84(1):46-49.
12. Dubbeld J, van Hoek B, Ringers J, et al. Biliary complications after liver transplantation from donation after cardiac death donors:an analysis of risk factors and long-term outcome from a single center. Ann Surg, 2015, 261(3):e64.
13. Yamamoto S, Wilczek HE, Duraj FF, et al. Liver transplantation with grafts from controlled donors after cardiac death:a 20-year follow-up at a single center. Am J Transplant, 2010, 10(3):602-611.
14. Evans PC, Smith S, Hirschfield G, et al. Recipient HLA-DR3, tumour necrosis factor-alpha promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are interrelated risk factors for chronic rejection of liver grafts. J Hepatol, 2001, 34(5):711-715.
15. Seehofer D, Eurich D, Veltzke-Schlieker W, et al. Biliary complica-tions after liver transplantation:old problems and new challenges. Am J Transplant, 2013, 13(2):253-265.
16. Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation:a meta-analysis. Ann Surg, 2011, 253(2):259-264.
17. D'Alessandro AM, Fernandez LA, Chin LT, et al. Donation after cardiac death:the University of Wisconsin experience. Ann Trans-plant, 2004. 9(1):68-71.
18. Wigmore SJ. Current challenges in liver transplantation following donation after cardiac death. Transplantation, 2010, 90(10):1048-1049.
19. Welling TH, Heidt DG, Englesbe MJ, et al. Biliary complications following liver transplantation in the model for end-stage liver disease era:effect of donor, recipient, and technical factors. Liver Transpl, 2008, 14(1):73-80.
20. Leithead JA, Tariciotti L, Gunson B, et al. Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury. Am J Transplant, 2012, 12(4):965-975.
21. Raia S, Nery JR, Mies S. Liver transplantation from live donors. Lancet, 1989, 2(8661):497.
22. Gad EH, Alsebaey A, Lotfy M, et al. Complications and mortality after adult to adult living donor liver transplantation:a retrospective cohort study. Ann Med Surg (Lond), 2015, 4(2):162-171.
23. Muiesan P, Vergani D, Mieli-Vergani G. Liver transplantation in children. J Hepatol, 2007, 46(2):340-348.
24. Tessier ME, Harpavat S, Shepherd RW, et al. Beyond the pediatric end-stage liver disease system:solutions for infants with biliary atresia requiring liver transplant. World J Gastroenterol, 2014, 20(32):11062-11068.
25. Kyoden Y, Tamura S, Sugawara Y, et al. Outcome of living donor liver transplantation for post-Kasai biliary atresia in adults. Liver Transpl, 2008, 14(2):186-192.
26. Duffy JP, Hong JC, Farmer DG, et al. Vascular complications of orthotopic liver transplantation:experience in more than 4 200 patients. J Am Coll Surg, 2009, 208(5):896-905.
27. 张明满, 任志美, 康权, 等. 亲属活体及心脏死亡器官捐赠供肝儿童肝移植51例疗效分析. 中华器官移植杂志, 2013, 34(12):712-715.
28. 刘敏, 罗庆, 迭小红, 等. 儿童心脏死亡器官捐献供肝肝移植术后肝动脉并发症的诊治体会. 中华小儿外科杂志, 2015, 36(4):282-285.
29. Reichman TW, Katchman H, Tanaka T, et al. Living donor versus deceased donor liver transplantation:a surgeon-matched comparison of recipient morbidity and outcomes. Transpl Int, 2013, 26(8):780-787.
30. Fisher RA, Cotterell AH, Maluf DG, et al. Adult living donor versus deceased donor liver transplantation:a 10-year prospective single center experience. Ann Hepatol, 2009, 8(4):298-307.
31. Wan P, Yu X, Xia Q. Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation:a systematic review and meta-analysis. Liver Transpl, 2014, 20(4):425-436.
32. Gómez CM, Dumonceau JM, Marcolongo M, et al. Endoscopic management of biliary complications after adult living-donor versus deceased-donor liver transplantation. Transplantation, 2009, 88 (11):1280-1285.
33. Li C, Mi K, Wen T, et al. Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation. PLoS One, 2011, 6(11):e27366.
34. Kulik LM, Fisher RA, Rodrigo DR, et al. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma:results of the A2ALL cohort. Am J Transplant, 2012, 12(11):2997-3007.
35. Vakili K, Pomposelli JJ, Cheah YL, et al. Living donor liver transp-lantation for hepatocellular carcinoma:increased recurrence but improved survival. Liver Transpl, 2009, 15(12):1861-1866.
36. Lo CM, Fan ST, Liu CL, et al. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg, 2007, 94(1):78-86.
37. Sandhu L, Sandroussi C, Guba M, et al. Living donor liver transp-lantation versus deceased donor liver transplantation for hepatoce-llular carcinoma:comparable survival and recurrence. Liver Transpl, 2012, 18(3):315-322.
38. Bhangui P, Vibert E, Majno P, et al. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma:living versus deceased donor transplantation. Hepatology, 2011, 53(5):1570-1579.
39. da Silva RF, Raphe R, Felício HC, et al. Prevalence, treatment, and outcomes of the hepatic artery stenosis after liver transplantation. Transplant Proc, 2008, 40(3):805-807.
40. Starzl TE, Groth CG, Brettschneider L, et al. Orthotopic homotran-splantation of the human liver. Ann Surg, 1968, 168(3):392-415.
41. Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg, 1989, 210(5):649-652.
42. Belghiti J, Panis Y, Sauvanet A, et al. A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion. Surg Gynecol Obstet, 1992, 175(3):270-272.
43. Mehrabi A, Mood ZA, Fonouni H, et al. A single-center experience of 500 liver transplants using the modified piggyback technique by Belghiti. Liver Transpl, 2009, 15(5):466-474.

Previous Article
DCD肝移植的展望
Next Article
A Report of 3 Cases and Literature Review of Combined Liver and Kidney Transplanta-tion after Renal Transplantation

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

DCD肝移植术后并发症的变迁

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content